Analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018. According to the report, the major cause of peptic ulcers is the increased incidence of H. pylori infections, which account for more than 80 percent of the total diagnosed cases of peptic ulcers. H. pylori infections are caused by food or water contamination, and lack of hygiene. Single User License Available US $2500 Complete Report Available @ http://www.reportsnreports.com/reports/295472-global-peptic-ulcer-drugs-market-2014-2018-.html

1. Global Peptic Ulcer Drugs Market 2014-2018
Published: August 2014
Single User PDF: US$ 2500
Corporate User PDF: US$ 3500
Order this report by calling
+1 888 391 5441 or Send an email
to sales@reportsandreports.com
with your contact details and
questions if any.
1© ReportsnReports.com / Contact sales@reportsandreports.com

2. Global Peptic Ulcer Drugs Market 2014-2018
One of the predominant emerging trends in this market is the use of combination drugs for the
treatment of peptic ulcers. Combination drugs can help improve the treatment for NSAID-induced
peptic ulcers.
A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small
intestine because of the caustic effect of the gastric acids and enzymes in these organs. The
symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The
major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by
bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori
infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic
ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.
Analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the
period 2013-2018. According to the report, the major cause of peptic ulcers is the increased
incidence of H. pylori infections, which account for more than 80 percent of the total diagnosed
cases of peptic ulcers. H. pylori infections are caused by food or water contamination, and lack of
hygiene.
Single User License Available at US $2500 Order a copy of this report at @
http://www.reportsnreports.com/Purchase.aspx?name=295472.
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
2© ReportsnReports.com / Contact sales@reportsandreports.com

3. Global Peptic Ulcer Drugs Market 2014-2018
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs
market for the period 2014–2018. To calculate the market size, the report considers the revenue
generated from the sales of various drugs used in the treatment of peptic ulcers that are available in
the market.
Global Peptic Ulcer Drugs Market 2014-2018, has been prepared based on an in-depth market
analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC
regions; it also covers the Global Peptic Ulcer Drugs market landscape and its growth prospects in the
coming years. The report also includes a discussion of the key vendors operating in this market.
Further, the report states that the adverse effect of PPIs used for the treatment of peptic ulcers is
one of the major challenges. PPIs are the most-effective treatment options but cause CDAD.
Inquiry Before Buying on this Report @
http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=295472.
Key Regions
Americas
EMEA
APAC
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
3© ReportsnReports.com / Contact sales@reportsandreports.com

4. Global Peptic Ulcer Drugs Market 2014-2018
Key Vendors
AstraZeneca plc
Eisai Co. Ltd.
Daewoong Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd.
Other Prominent Vendors
Daiichi Sankyo
Dr. Reddy''s Laboratories
Eumedica
Ferring Pharmaceuticals
Horizon Pharma
Johnson and Johnson
Merck Sharp and Dohme
Otsuka Holdings
Pfizer
PharmaKing
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
4© ReportsnReports.com / Contact sales@reportsandreports.com

5. Global Peptic Ulcer Drugs Market 2014-2018
Market Driver
Increased Incidence of H. pylori Infections.
Market Challenge
Adverse Effect of PPIs.
Market Trend
Use of Combination Drugs.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=295472.
Browse more report on Pharmaceuticals Market
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
5© ReportsnReports.com / Contact sales@reportsandreports.com